Introduction
Biliary tract cancers (BTC) comprise a heterogeneous group of neoplasms including gallbladder cancer, intrahepatic cholangiocarcinoma, extrahepaticcholangiocarcinoma and variably, ampullary carcinoma. Biliary tract carcinomas are relatively rare, representing less than 1% of cancers [1] . These tumors present a significant therapeutic challenge in that they are often diagnosed at an advanced stage when surgical resection is not feasible and treatment options are limited. Thus, research efforts have concentrated on identifying potential markers of neoplasia that can be incorporated into diagnostic tests and therapeutic modalities for use in individuals at risk for these lethal malignancies.
This review aims to introduce the main features of the important molecular markers of biliary tree tumors. Some considerable tumor markers are Mucin 1 , Mucin 2 , Mucin 4 and CyclinD1.
II.
Aims And Objectives 1.To study the distribution of molecular markers among cases and control for predictive value,sensitivity and specificity. 2.To study the role of molecular markers in outcome of BTM{prognosis of BTM}
III. Materials And Method
A prospective observational study was conducted in Department Of Surgery, NORTHERN RAIlways Central Hospital, New Delhi, from August 2013 to May 2015.In our study we have taken 70 patients who fulfilled the inclusion and exclusion criteria, in all these patients, thorough history was taken and detailed clinical examination was performed, alone with relevant investigations, After preliminary investigation, pre anesthetic checkup, patients were taken up for surgery (whose investigation suggestive of malignancy and are operable) and specimen sent for histopathology and for molecular markers study. Patients whose biopsy are positive for malignancy were taken under case group and those whom investigation were suggestive of malignancies but histopathology negative for malignancy are categorized under control group.
Follow up: All cases were followed up at regular interval of 3 months for first year and 6 monthly there after. At each visit a thorough clinical examination was done to look for features suggestive of metastasis and relevant radiological investigation(USG Abdomen, CECT whole Abdomen) done accordingly whereas controls were followed at 6 monthly interval for first year then annually thereafter. Out of 70 patients, maximum no. of patients are female with 65.71 % having an approximate ratioof male:female of 1:2. Since all patients were suspicious of malignancy on radiological background but true positive (biopsy proven malignant) were only 42.86%. 
V. Discussion
This review aims to introduce the main features of the some important molecular markers of biliary tract tumors. My study include 70 patients who were suspicious of biliary tract malignancy, there is uneven age and gender distribution with maximum number of patients (36 of 70) between 50-60 years age group and female (n=46,65.71%) to male (n=24,34.29%) ratio of 2:1.
Among these 70 patient biopsy was positive for malignancy in 30 (42.86%), these were designated as cases and those found negative were designated as controls 40/70(57.14%).
Among cases all 30/30(100%) were adenocarcinoma and as per tumour differentiation categorize as high grade18/30(60%) and low grade12/30(40%) (Well differentiated).
In our study when distribution of molecular markers was observed as per benign (controls) and malignant carcinoma (cases) it was found to have significant difference (P-value <0.05) for Muc-1 and Cyclin D1.
Among these markers Muc-1 expression are more specific whereas cyclin D1 expression is more sensitive indicator in differentiating between benign and malignant carcinomas.
Expression of Muc-2, Muc-4 was also higher in malignant cases than benign conditions mimicking carcinoma on radiological background but was statistically insignificant(P-value>0.05).
In present study when distribution of molecular markers among cases (BTC) was observed it was found to be statistically significant (P-value <0.05) for Muc-1, Cyclin D1 thereby signifying their role in pathogenisis of BTC.
Expression of molecular markers among biliary tract malignancy (cases) in present study and their comparison with different studies: In our study when expression of molecular markers was observed as per grade of malignancy,expression of Muc-4 significantly (p-value <0.05) correlates with high grade of malignancy.Expression of Muc1 is also more frequent in high grade malignancy, whereas expression of Muc-2, Cyclin D1 is usually associated with low grade malignancy but is statistically insignificant. [2] concluded that patients with MUC4 expression had significantly worse survival than those without MUC4 expression (P = 0.048), in a study on cyclin D1significance in BTC[155] Ai-Min Hui et al concluded that cyclin D1 over expression was significantly related to decreased overall survival (P < 0.05) in patients with GBC [7] .
IV. Conclusion
Cholangiocarcinoma is commonly considered a rare cancer. However, if we consider the hepato-biliary system a single entity, cancers of the gallbladder, intra-hepatic and extra-hepatic biliary tree altogether represent approximately 30% of the total with incidence rates close to that of hepatocellular carcinoma, which is the third most common cause of cancer-related death worldwide.The treatment is still quite unsuccessful and bile duct malignancies have overall poor prognosis. When untreated, bile duct malignancies lead to death usually within a few months [3] [4] .Biomarkers for screening programs and for follow-up of categories at risk are under investigation, however, currently none of the proposed markers has reached clinical application. For all these considerations, cancers of the biliary tree system should merit much more scientific attention also because a progressive increasein incidence and mortality for these cancers has been reported worldwideMuc-1 expression are more specific whereas cyclin D1 expression is more sensitive indicator in differentiating between benign and malignant biliary tract carcinomas in our study.
The expression of Muc-4 significantly correlates with grade of malignancy and is more frequent in high grade malignancy in our study.Among these molecular markers expression of Muc-2 significantly affect outcome and its expression is associated with better outcome in patients with Biliary tract malignancy in our study.
Given the smaller number of patients with BTC as compared with other common solid tumors, coordination of trials among institutions and cooperative groups, both nationally and internationally, and optimizing trial design, will be the key to future progress.
